Abstract: A method utilizing GM-CSF to promote accelerated wound healing in mammals is described. This method comprises administering topically to the mammal a therapeutically effective amount of this polypeptide. In addition, such methods comprising admixtures containing GM-CSF and at least one other protein are also disclosed.